Chinese Journal of Dermatology ›› 2021, Vol. 54 ›› Issue (9): 835-838.doi: 10.35541/cjd.20210362
• Reviews • Previous Articles
Qiu Yueqi, Fu Siqi, Luo Shuaihantian, Li Yaping, Zhang Guiying
Received:
2021-05-06
Revised:
2021-06-03
Online:
2021-09-15
Published:
2021-09-02
Contact:
Luo Shuaihantian
E-mail:lsht5309@csu.edu.cn
Supported by:
Qiu Yueqi, Fu Siqi, Luo Shuaihantian, Li Yaping, Zhang Guiying. Research advance in androgenetic alopecia in 2020[J]. Chinese Journal of Dermatology, 2021, 54(9): 835-838.doi:10.35541/cjd.20210362
[1] | Wang TL, Zhou C, Shen YW, et al. Prevalence of androgenetic alopecia in China: a community⁃based study in six cities[J]. Br J Dermatol, 2010,162(4):843⁃847. doi: 10.1111/j.1365⁃2133. 2010.09640.x. |
[2] | 中国医师协会美容与整形医师分会毛发整形美容专业委员会. 中国人雄激素性脱发诊疗指南[J]. 中国美容整形外科杂志, 2019,30(1):6. doi: 10.3969/j.issn.1673⁃7040.2019.01.001. |
[3] | Kobielak K, Pasolli HA, Alonso L, et al. Defining BMP functions in the hair follicle by conditional ablation of BMP receptor IA[J]. J Cell Biol, 2003,163(3):609⁃623. doi: 10.1083/jcb.2003 09042. |
[4] | Higgins CA, Chen JC, Cerise JE, et al. Microenvironmental reprogramming by three⁃dimensional culture enables dermal papilla cells to induce de novo human hair⁃follicle growth[J]. Proc Natl Acad Sci U S A, 2013,110(49):19679⁃19688. doi: 10.1073/pnas.1309970110. |
[5] | Ceruti JM, Oppenheimer FM, Leirós GJ, et al. Androgens downregulate BMP2 impairing the inductive role of dermal papilla cells on hair follicle stem cells differentiation[J]. Mol Cell Endocrinol, 2021,520:111096. doi: 10.1016/j.mce.2020. 111096. |
[6] | Belgardt E, Steinberg T, Husari A, et al. Force⁃responsive Zyxin modulation in periodontal ligament cells is regulated by YAP rather than TAZ[J]. Cell Signal, 2020,72:109662. doi: 10.1016/j.cellsig.2020.109662. |
[7] | Wang Y, Gilmore TD. Zyxin and paxillin proteins: focal adhesion plaque LIM domain proteins go nuclear[J]. Biochim Biophys Acta, 2003,1593(2⁃3):115⁃120. doi: 10.1016/s0167⁃4889(02)00349⁃x. |
[8] | Liu Q, Shi X, Zhang Y, et al. Increased expression of Zyxin and its potential function in androgenetic alopecia[J]. Front Cell Dev Biol, 2020,8:582282. doi: 10.3389/fcell.2020.582282. |
[9] | Seleit I, Bakry OA, Badr E, et al. Vitamin D receptor gene polymorphisms Taq⁃1 and Cdx⁃1 in female pattern hair loss[J]. Indian J Dermatol, 2020,65(4):259⁃264. doi: 10.4103/ijd.IJD_482_18. |
[10] | Hu S, Li Z, Lutz H, et al. Dermal exosomes containing miR⁃218⁃5p promote hair regeneration by regulating β⁃catenin signaling[J]. Sci Adv, 2020,6(30):eaba1685. doi: 10.1126/sciadv.aba1685. |
[11] | Deng W, Hu T, Han L, et al. miRNA microarray profiling in patients with androgenic alopecia and the effects of miR⁃133b on hair growth[J]. Exp Mol Pathol, 2021,118:104589. doi: 10.1016/j.yexmp.2020.104589. |
[12] | Rakowska A, Slowinska M, Kowalska⁃Oledzka E, et al. Dermoscopy in female androgenic alopecia: method standardization and diagnostic criteria. Int J Trichology, 2009,1(2):123⁃30. doi: 10.4103/0974⁃7753.58555. |
[13] | Lee WS, Ro BI, Hong SP, et al. A new classification of pattern hair loss that is universal for men and women: basic and specific (BASP) classification[J]. J Am Acad Dermatol, 2007,57(1):37⁃46. doi: 10.1016/j.jaad.2006.12.029. |
[14] | Chung Y, Lee SH, Choi SK. Fundamental basis of scalp layering techniques to protect against wound infection: a comparative study between conventional and in⁃to⁃out dissection of the superficial temporal artery[J]. World Neurosurg, 2017,97:304⁃311. doi: 10.1016/j.wneu.2016.10.002. |
[15] | Soga S, Koyama T, Mikoshi A, et al. MR imaging of hair and scalp for the evaluation of androgenetic alopecia[J]. Magn Reson Med Sci, 2021,20(2):160⁃165. doi: 10.2463/mrms.mp. 2020⁃0026. |
[16] | Kerkemeyer KL, de Carvalho LT, Jerjen R, et al. Female pattern hair loss in men: a distinct clinical variant of androgenetic alopecia[J]. J Am Acad Dermatol, 2020,S0190⁃9622(20)32632⁃3. doi: 10.1016/j.jaad.2020.09.042. |
[17] | Banihashemi M, Nahidi Y, Meibodi NT, et al. Serum vitamin D3 level in patients with female pattern hair loss[J]. Int J Trichology, 2016,8(3):116⁃120. doi: 10.4103/0974⁃7753.188965. |
[18] | York K, Meah N, Bhoyrul B, et al. A review of the treatment of male pattern hair loss[J]. Expert Opin Pharmacother, 2020,21(5):603⁃612. doi: 10.1080/14656566.2020.1721463. |
[19] | Nguyen D⁃D, Marchese M, Cone EB, et al. Investigation of suicidality and psychological adverse events in patients treated with finasteride[J]. JAMA Dermatol. 2021,157(1):35⁃42. doi: 10.1001/jamadermatol.2020.3385. |
[20] | Jimenez⁃Cauhe J, Saceda⁃Corralo D, Rodrigues⁃Barata R, et al. Characterization and management of hypertrichosis induced by low⁃dose oral minoxidil in the treatment of hair loss[J]. J Am Acad Dermatol, 2021,84(1):222⁃223. doi: 10.1016/j.jaad.2020. 08.124. |
[21] | Randolph M, Tosti A. Oral minoxidil treatment for hair loss: a review of efficacy and safety[J]. J Am Acad Dermatol, 2021,84(3):737⁃746. doi: 10.1016/j.jaad.2020.06.1009. |
[22] | Rodrigues⁃Barata R, Moreno⁃Arrones OM, Saceda⁃Corralo D, et al. Low⁃dose oral minoxidil for female pattern hair loss: a unicenter descriptive study of 148 women[J]. Skin Appendage Disord, 2020,6(3):175⁃176. doi: 10.1159/000505820. |
[23] | Dubin DP, Lin MJ, Leight HM, et al. The effect of platelet⁃rich plasma on female androgenetic alopecia: a randomized controlled trial[J]. J Am Acad Dermatol, 2020,83(5):1294⁃1297. doi: 10. 1016/j.jaad.2020.06.1021. |
[24] | Shapiro J, Ho A, Sukhdeo K, et al. Evaluation of platelet⁃rich plasma as a treatment for androgenetic alopecia: a randomized controlled trial[J]. J Am Acad Dermatol, 2020,83(5):1298⁃1303. doi: 10.1016/j.jaad.2020.07.006. |
[25] | Zhou Y, Yu S, Zhao J, et al. Effectiveness and safety of botulinum toxin type A in the treatment of androgenetic alopecia[J]. Biomed Res Int, 2020,2020:1501893. doi: 10.1155/2020/1501893. |
[26] | Shin H, Won CH, Chung WK, et al. Up⁃to⁃date clinical trials of hair regeneration using conditioned media of adipose⁃derived stem cells in male and female pattern hair loss[J]. Curr Stem Cell Res Ther, 2017,12(7):524⁃530. doi: 10.2174/1574888X126 66170504120244. |
[27] | Tak YJ, Lee SY, Cho AR, et al. A randomized, double⁃blind, vehicle⁃controlled clinical study of hair regeneration using adipose⁃derived stem cell constituent extract in androgenetic alopecia[J]. Stem Cells Transl Med, 2020,9(8):839⁃849. doi: 10.1002/sctm.19⁃0410. |
[28] | Uzel B, Takano G, Chartuni J, et al. Intradermal injections with 0.5% minoxidil for the treatment of female androgenetic alopecia: a randomized, placebo⁃controlled trial[J]. Dermatol Ther, 2021,34(1):e14622. doi: 10.1111/dth.14622. |
[29] | Kutlu Ö. Dexpanthenol may be a novel treatment for male androgenetic alopecia: analysis of nine cases[J]. Dermatol Ther, 2020,33(3):e13381. doi: 10.1111/dth.13381. |
[30] | Kutlu Ö, Metin A. Systemic dexpanthenol as a novel treatment for female pattern hair loss[J]. J Cosmet Dermatol, 2021,20(4):1325⁃1330. doi: 10.1111/jocd.13729. |
[31] | Ismail FF, Meah N, Trindade de Carvalho L, et al. Safety of oral bicalutamide in female pattern hair loss: a retrospective review of 316 patients[J]. 2020,83(5):1478⁃1479. doi: 10.1016/j.jaad.2020.03.034. |
[32] | Exicure and allergan enter into collaboration, option and license agreement to discover and develop sna⁃based treatments for hair loss disorders[EB/OL]. https://www.businesswire.com/news/home/ 20191114005106/en/Exicure⁃Allergan⁃Enter⁃Collaboration⁃Option⁃License⁃Agreement. |
[33] | Lee J, Bӧscke R, Tang PC, et al. Hair follicle development in mouse pluripotent stem cell⁃derived skin organoids[J]. Cell Rep, 2018,22(1):242⁃254. doi: 10.1016/j.celrep.2017.12.007. |
[34] | Lee J, Rabbani CC, Gao H, et al. Hair⁃bearing human skin generated entirely from pluripotent stem cells[J]. Nature, 2020,582(7812):399⁃404. doi: 10.1038/s41586⁃020⁃2352⁃3. |
[1] | China Dermatologist Association. Guidelines for the management of chronic pruritus (2024) [J]. Chinese Journal of Dermatology, 2024, 57(5): 387-399. |
[2] | Mycobacteriosis Research Group, China “Belt and Road” Dermatology Alliance, Division of Dermatology and STI Diagnosis, Chinese Association on Leprosy. Expert consensus on the clinical diagnosis and treatment of cutaneous tuberculosis in China (2024) [J]. Chinese Journal of Dermatology, 2024, 57(5): 426-434. |
[3] | China Dermatologist Association, Combination of Traditional and Western Medicine Dermatology. Diagnosis and treatment of erythrodermic psoriasis: a Chinese expert consensus statement (2024) [J]. Chinese Journal of Dermatology, 2024, 57(5): 409-417. |
[4] | Mycology Group, Combination of Traditional and Western Medicine Dermatology, Chinese Antifungal-Resistant Dermatophytosis Expert Consensus Group. Expert consensus on the diagnosis, treatment, prevention and control of antifungal-resistant dermatophyte infections in China (2024) [J]. Chinese Journal of Dermatology, 2024, 57(5): 418-425. |
[5] | Liu Yi, Qu Ying, Lei Wenzhi, Liu Xiaogang, Pan Weihua, Zhang Chao. Clinical efficacy of salt-packing therapy in the treatment of pyogenic granuloma [J]. Chinese Journal of Dermatology, 2024, 0(4): 20230553-e20230553. |
[6] | Ju Qiang, Li Jiaqi. Acne vulgaris revisited: from pathogenesis to treatment strategies [J]. Chinese Journal of Dermatology, 2024, 57(4): 289-294. |
[7] | Zhang Dimin, Cao Cheng, Zhou Miaoni, Sheng Anqi, Lin Fuquan, Xu Ai′e. Analysis of disease control rate and its influencing factors in patients with progressive non-segmental vitiligo after combined treatment with compound betamethasone injection [J]. Chinese Journal of Dermatology, 2024, 57(4): 350-354. |
[8] | Wang Yimeng, Wu Wenting, Zhang Qian, Zhang Chunlei, Li Weiwei. Clinical and pathological diagnoses of 389 patients with primary solid tumors localized in the perianal and external genitalia regions [J]. Chinese Journal of Dermatology, 2024, 57(4): 316-323. |
[9] | Yue Shuzhen, Shu Ye, Luo Yangyang, Li Keyao, Zhang Yuanyuan, Tang Jianping, Wei Zhu. Efficacy and safety of omalizumab in the treatment of chronic urticaria in children: a retrospective study [J]. Chinese Journal of Dermatology, 2024, 57(4): 354-358. |
[10] | Ge Xinhong, Ma Yingdong, Jiao Yaning, Liu Lingling, Zhou Mei, Zi Wei, Li Bowen. Analysis of efficacy and safety of 532-nm picosecond laser in the treatment of early-stage facial seborrheic keratosis [J]. Chinese Journal of Dermatology, 2024, 57(4): 359-362. |
[11] | Yan Rufan, Liao Jieyue, Guo Ziyu, Yao Nan, Zhou Wenyu, Luo Shuaihantian, Zhang Guiying, Zhao Ming. Pathogenesis and targeted therapy of pemphigus [J]. Chinese Journal of Dermatology, 2024, 57(4): 374-378. |
[12] | Yang Yuting, Gu Guolin, Wu Minjuan, Sheng Zhijie, Li Jin, Mo Xingfan, Wu Minzhi, Xu Ping, . Application of serum fibronectin in combination with non-treponemal antibody testing in the exclusion of asymptomatic neurosyphilis among serofast syphilis patients: a preliminary study [J]. Chinese Journal of Dermatology, 2024, 57(3): 246-249. |
[13] | Hospital for Skin Diseases, Chinese Academy of Medical Sciences, National Center for STD Control, Chinese Center for Disease Control and Prevention, Venereology Group, Chinese Society of Dermatology, Chinese Association Rehabilitation of Dermatology . Chinese expert consensus on the diagnosis and treatment of Mycoplasma genitalium infection (2024) [J]. Chinese Journal of Dermatology, 2024, 57(3): 201-208. |
[14] | Wang Liuyuan, Zhang Xiaohui, Luo Danyang, Ke Wujian, Xue Yaohua, Huang Jinmei, Li Changchang, Zhao Peizhen, Yang Ligang, . A survey on the current status of standardized diagnosis and treatment services for sexually transmitted diseases in medical institutions in Guangdong province [J]. Chinese Journal of Dermatology, 2024, 57(3): 218-223. |
[15] | Chen Nana, Li Zheng, Zhang Jie, Li Shishen, Li Wei. Early infection status among 147 cases of latent syphilis in Nanning city: a cross-sectional survey [J]. Chinese Journal of Dermatology, 2024, 57(3): 213-217. |
|